Sight Sciences, Inc.
SGHTSight Sciences reported FY 2025 revenue of $77.4 million, generating a gross profit of $66.7 million.
NASDAQ
Healthcare
$3.51
-0.15(-4.10%)
Mkt Cap $190M
$2.09
$9.05
52-Week Range
AI-generated
Sight Sciences reported FY 2025 revenue of $77.4 million, generating a gross profit of $66.7 million.
Revenue breakdown: Surgical Glaucoma (96.4%), Dry Eye (3.6%).
$190MMkt Cap
$79MRev TTM
-$39MNI TTM
-5.0xP/E
Latest Earnings
10-K
FY FY2025Mar 3, 2026Sight Sciences reported FY 2025 revenue of $77.4 million, generating a gross profit of $66.7 million. The company incurred a net loss of $38.4 million, an improvement from a net loss of $51.5 million in FY 2024. Operating expenses totaled $103.8 million, primarily driven by selling, general and administrative costs of $89.2 million. The company ended the year with $92.0...
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
Surgical Glaucoma96.4%($152M)
Dry Eye3.6%($6M)
Analyst View
Company Profile
CIK0001531177
ISINUS82657M1053
CUSIP82657M105
Phone877 266 1144
Address4040 Campbell Avenue, Menlo Park, CA, 94025, US
SEC EDGAR